www.globalhumanceuticals.com
Global Humanceuticals - Prevention And Treatment Of HIV / AIDS

 Home Who We Are Contact Us  
 

  Global Humanceuticals, Inc. 2006

African Americans: Overview

African Americans: OverviewAmong diseases that disproportionately affect African Americans, HIV/AIDS has had a particularly devastating effect. At every stage―from HIV diagnosis through the death of persons with AIDS―the hardest-hit racial or ethnic group is African Americans.

Overall, even though African Americans make up only approximately 13% of the US population, one half of the estimated new numbers of HIV/AIDS diagnoses in the United States in 2004 were for African Americans.*

Race/ethnicity of adults and adolescents with HIV/AIDS diagnosed in 2004

Note. Based on data from 35 areas with long-term, confidential, name-based HIV reporting.

African Americans: OverviewAIDS has become a leading cause of death for African Americans. In 2002 (the most recent year for which data are available), HIV/AIDS was the second leading cause of death for all African Americans aged 35–44. In the same year, HIV/AIDS was the number 1 cause of death for African American women aged 25–34.

The cumulative toll (from the beginning of the epidemic through 2004) of AIDS is sobering.

  • Of the almost 1 million cases of AIDS diagnosed in the United States and its dependencies, possessions, and associated nations, 40% were in African Americans.
  • Of the more than half a million people with AIDS who have died, 38% were African Americans.

In 2002, HIV/AIDS was the number 1 cause of death for African American women aged 25-34.

It is not an exaggeration to say that HIV/AIDS is an epidemic in the African American community.

Quick Facts:

  • African Americans have accounted 40% of AIDS diagnoses since the beginning of the epidemic.
  • African Americans do not live as long as people in other racial or ethnic groups who have AIDS.
  • In 2004,more African American children (under the age of 13) were living with AIDS than were children of all other races and ethnicities living with AIDS combined.

* The estimated number of new HIV/AIDS diagnoses is derived from 35 areas with long-term, confidential name-based HIV reporting. The 35 areas include the US Virgin Islands, Guam, and 33 states: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming.

Data source: Centers for Disease Control & Prevention Website
 

Liability: Global Humanceuticals, Inc. does not warrant or assume any legal liability or responsibility for the accuracy or completeness of any information disclosed on www.globalhumanceuticals.com website.

Medical information: Global Humanceuticals, Inc. does not intend to provide specific medical advice or treatment. Global Humanceuticals, Inc. intends to provide the website visitors with documents and information to better understand HIV / AIDS and its prevention and treatment.
 
  Design and Development
  300Pix
Donate Now | Home | Who We Are | Roger K. Hershline, Ph.D. MD | Contact Us
Learn About HIV / AIDS | What Is This Medication | Why Is This Medication So Important
Events And Newsletters | The Patent | Cure HIV, Inc.